期刊文献+

化疗前应用GnRH类似物-诺雷德对乳腺癌患者月经复潮的影响

Effect of zoladex administered before chemotherapy on menstruation of patients with breast cancer
下载PDF
导出
摘要 目的:观察化疗前应用GnRH类似物-诺雷德对需进行术后辅助化疗并且有维持正常月经要求女性月经复潮的影响。方法:对确诊为乳腺癌并有维持正常月经要求的女性患者随机分成试验组(化疗前应用诺雷德组)和对照组(常规化疗组),比较两组的化疗后的月经来潮情况。结果:21例乳腺癌患者均可完成治疗,化疗后月经周期紊乱。试验组、对照组复潮各为72.7%,50%,P<0.05,差异有显著意义。结论:常规化疗会导致患者提前永久性闭经,月经恢复与年龄相关,化疗前应用诺雷德,可以有效地保护其卵巢功能,维持正常月经。 Objective:To observe the effect of zoladex to protect the ovarian function in the patients with breast cancer requiring for fertility or/and maintenance of normal hormone level before chemotherapy.Methods:Patients with breast cancer requiring for fertility or/and maintenance of normal hormone level were randomly divided into test group and control group.We compared the menstruation status after chemotherapy between the two groups.Results:These 21 breast cancer patients completed the treatment.The rates of the return of menstruation in the test group and the control group were 72.7% and 50%,respectively(P =0.039).Conclusion:Conventional chemotherapy may lead to permanent amenorrhea in advance and the recovery of menstruation is age-related.Zoladex administered before chemotherapy can effectively protect the ovarian function and fertility or/and maintenance of normal hormone level.
作者 孙晶波
出处 《现代肿瘤医学》 CAS 2012年第12期2501-2503,共3页 Journal of Modern Oncology
关键词 乳腺癌 诺雷德 卵巢功能 化学治疗 breast cancer zoladex ovarian function chemotherapy
  • 相关文献

参考文献11

二级参考文献27

  • 1Lu LUO Feng-chuan ZHU Yao-ying ZENG.The Mechanisms of Abnormal Bleeding in Patients with Anovulatory Dysfunctional Uterine Bleeding[J].Journal of Reproduction and Contraception,2002,13(4):222-230. 被引量:3
  • 2牛建昭,魏育林,艾浩,薛晓鸥.临床化疗对卵巢功能的影响[J].中日友好医院学报,2006,20(3):181-183. 被引量:9
  • 3Huo, X,Hu, Z. B,Zhai, X. J,Wang, Y,Wang, S,Wang, X. C,Qin, J. W,Chen, W. S,Jin, G. F,Liu, J. Y,Gao, J,Wei, Q. Y,Wang, X. R,Shen, H. B.Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility:a case-control analysis[J].南京医科大学学报(自然科学版),2007,27(7):743-743. 被引量:3
  • 4Mouridsen H, Gershanovieh M, Sun Y, et al. Superior efficacy of letrozole versus tamoxifen as first - line therapy for with advaneed breast cancer results of a phase Ⅲ study of the International Letrozole Breast Cancer Group [ J ]. J Clin Oneol,2001,19 ( 10 ) :2596 - 2606. 被引量:1
  • 5Baum M, Budzax AU, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial[J]. Lanctet,2002,359 (9324) :2131 - 2139. 被引量:1
  • 6Goss PE, Reid C, Pintilie M. Male breast carcinoma: A review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955 - 1996 [ J ]. Cancer, 1999,85:629 - 639. 被引量:1
  • 7Ellis, Coop A, Singh B, et al. Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status[ J]. Cancer Res ,2003,63 ( 19 ) :6523 - 6531. 被引量:1
  • 8Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopansal breast cancer patients with letrozole: a randomized double - blind multicenter study [ J ]. Ann Oncol, 2001,12 ( 11 ) : 1527 - 1532. 被引量:1
  • 9Early Breast Cancer Trialists' Collaborative Group.Ovarian ablation in early breast cancer:overview of the randomised trials[J].Lancet,1996,348(9036):1189-1196. 被引量:1
  • 10Jonat W,Kaufmann M,Sauerbrei W,et al.Goserelin versus cyclophosphamide,methotrexate,and fl uorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer:The Zoladex Early Breast Cancer Research Association study[J].J Clin Oncol,2002,20(24):4628-4635. 被引量:1

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部